FGF21 and obesity disorder: It is known that patients with obesity, T2DM, and metabolic diseases tend to have high FGF21 levels but attenuated FGF21 signaling responses; therefore, previous research has further proposed that obesity, T2DM, and metabolic diseases are in an FGF21-resistant state13.